Aurobindo Pharma board recommends final dividend

Aurobindo Pharma has informed that the Board of Directors of the Company at its meeting held on May 29, 2012, has recommended final dividend at the rate of 100% on the equity share capital of the Company i.e. Re. 1 per share subject to approval of members.

The above information is part of company’s filing submitted to the BSE.